Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 59651-847

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 59651-847). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label.principal Display Panel (100 mg (100 Tablets Bottle))

Package Label.principal Display Panel (100 mg (100 Tablets Bottle))
This text provides information about extended-release tablets containing Bupropion hydrochloride 100 mg, marketed as Zyban®. The tablets are distributed by Aurobindo Pharma USA, Inc. and should be dispensed in a tight, light-resistant container. The warning advises against combining this medication with other forms of bupropion hydrochloride. The storage temperature is specified, and pharmacists are instructed to dispense the medication with an accompanying patient guide. Instructions to protect the tablets from light and moisture are also included. The usual adult dosage and information on accessing medication guides are provided as well.*
FDA Label Image

Package Label.principal Display Panel (150 mg (100 Tablets Bottle))

Package Label.principal Display Panel (150 mg (100 Tablets Bottle))
Each extended-release tablet contains Bupropion hydrochloride 150 mg. It is dispensed in a tight, light-resistant container with a child-resistant closure. This medication is manufactured by Aurobindo Pharma USA, Inc. The tablets should be stored at room temperature, protected from light and moisture. It is important not to use this medication in combination with ZYBAN or other medicines containing bupropion hydrochloride. The usual adult dosage information is available in the prescribing guide included with the medication. Additional details for pharmacists, such as how to dispense the medication and where to print medication guides, can be found at the website provided.*
FDA Label Image

Package Label.principal Display Panel (200 mg (100 Tablets Bottle))

Package Label.principal Display Panel (200 mg (100 Tablets Bottle))
This is a medication description for an extended-release tablet containing Bupropion Hydrochloride, USP 200 mg. It is manufactured by GlaxoSmithKline and distributed by Aurobindo Pharma USA, Inc. The medication should be stored in a tight, light-resistant container at 20° to 25°C (68° to 77°F) and out of reach of children. It is important not to combine this medication with any other medicines containing bupropion hydrochloride and to follow the guidance provided by the prescribing information. Additional details about dosage and administration should be obtained from the accompanying prescribing information or Medication Guides, available at the provided website.*
FDA Label Image

Str (Buprop Str)

Str (Buprop Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.